星空体育官方入口网站网址大全-登录入口官网

#三联治疗#

11篇内容 | 871人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1738240, encodeId=d97a1e38240e0, content=<a href='/topic/show?id=cbea19e8944' target=_blank style='color:#2F92EE;'>#三联治疗#</a>, objectTitle=Ann Intern Med：经皮冠状动脉介入治疗后房颤双联和三联治疗效果比较, objectType=article, longId=190318, objectId=173719031898, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=173719031898, replyNumber=0, likeNumber=107, createdTime=2020-05-26, rootId=0, userName=12498768m24(暂无昵称), userId=6bb734392571, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=173719031898, moduleTitle=Ann Intern Med：经皮冠状动脉介入治疗后房颤双联和三联治疗效果比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=173719031898)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738239, encodeId=e1091e3823974, content=<a href='/topic/show?id=cbea19e8944' target=_blank style='color:#2F92EE;'>#三联治疗#</a>, objectTitle=BMJ：COPD：三联治疗PK双药或单药治疗, objectType=article, longId=154644, objectId=082b1546442a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=082b1546442a, replyNumber=0, likeNumber=91, createdTime=2018-12-13, rootId=0, userName=12498768m24(暂无昵称), userId=6bb734392571, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=082b1546442a, moduleTitle=BMJ：COPD：三联治疗PK双药或单药治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=082b1546442a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738238, encodeId=15351e38238f4, content=<a href='/topic/show?id=cbea19e8944' target=_blank style='color:#2F92EE;'>#三联治疗#</a>, objectTitle=Int J Cardiol：接受口服抗凝剂治疗的冠状动脉支架植入患者双重治疗与三联治疗比较, objectType=article, longId=146292, objectId=175814629227, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=175814629227, replyNumber=0, likeNumber=89, createdTime=2018-11-17, rootId=0, userName=12498768m24(暂无昵称), userId=6bb734392571, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=175814629227, moduleTitle=Int J Cardiol：接受口服抗凝剂治疗的冠状动脉支架植入患者双重治疗与三联治疗比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=175814629227)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738233, encodeId=f95d1e3823385, content=<a href='/topic/show?id=cbea19e8944' target=_blank style='color:#2F92EE;'>#三联治疗#</a>, objectTitle=Ann Inter Med：RA治疗方案成本效益谁更好：二联治疗&三联治疗？, objectType=article, longId=100473, objectId=cda41004e318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cda41004e318, replyNumber=0, likeNumber=81, createdTime=2017-09-30, rootId=0, userName=12498768m24(暂无昵称), userId=6bb734392571, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cda41004e318, moduleTitle=Ann Inter Med：RA治疗方案成本效益谁更好：二联治疗&三联治疗？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cda41004e318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738236, encodeId=59671e38236fa, content=<a href='/topic/show?id=cbea19e8944' target=_blank style='color:#2F92EE;'>#三联治疗#</a>, objectTitle=ESC全新重磅：房颤患者支架置入术后使用达比加群酯双联治疗大出血发生率显著低于华法林三联治疗, objectType=article, longId=111167, objectId=ca0111116eb1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca0111116eb1, replyNumber=0, likeNumber=80, createdTime=2018-07-11, rootId=0, userName=12498768m24(暂无昵称), userId=6bb734392571, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca0111116eb1, moduleTitle=ESC全新重磅：房颤患者支架置入术后使用达比加群酯双联治疗大出血发生率显著低于华法林三联治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ca0111116eb1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738237, encodeId=f9041e38237cd, content=<a href='/topic/show?id=cbea19e8944' target=_blank style='color:#2F92EE;'>#三联治疗#</a>, objectTitle=Am J Resp Crit Care:慢阻肺患者：三联治疗vs ICS/LABA, objectType=article, longId=113643, objectId=5d5111364314, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d5111364314, replyNumber=0, likeNumber=85, createdTime=2018-05-27, rootId=0, userName=12498768m24(暂无昵称), userId=6bb734392571, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d5111364314, moduleTitle=Am J Resp Crit Care:慢阻肺患者：三联治疗vs ICS/LABA, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5d5111364314)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738234, encodeId=3cd71e38234c9, content=<a href='/topic/show?id=cbea19e8944' target=_blank style='color:#2F92EE;'>#三联治疗#</a>, objectTitle=Intern Med J：难治性幽门螺杆菌感染：基于左氧氟沙星的三联治疗可委以重任, objectType=article, longId=106487, objectId=515110648e78, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=515110648e78, replyNumber=0, likeNumber=63, createdTime=2017-09-01, rootId=0, userName=12498768m24(暂无昵称), userId=6bb734392571, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=515110648e78, moduleTitle=Intern Med J：难治性幽门螺杆菌感染：基于左氧氟沙星的三联治疗可委以重任, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=515110648e78)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738235, encodeId=0e551e3823539, content=<a href='/topic/show?id=cbea19e8944' target=_blank style='color:#2F92EE;'>#三联治疗#</a>, objectTitle=Ann Intern Med:活动性类风湿关节炎三联治疗vs生物治疗：成本效果分析, objectType=article, longId=107706, objectId=f75c10e70678, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f75c10e70678, replyNumber=0, likeNumber=75, createdTime=2017-08-21, rootId=0, userName=12498768m24(暂无昵称), userId=6bb734392571, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f75c10e70678, moduleTitle=Ann Intern Med:活动性类风湿关节炎三联治疗vs生物治疗：成本效果分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f75c10e70678)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738232, encodeId=2ef41e382324f, content=<a href='/topic/show?id=cbea19e8944' target=_blank style='color:#2F92EE;'>#三联治疗#</a>, objectTitle=Gastroenterology：降低利巴韦林剂量为控制三联治疗1型HCV感染患者继发贫血的**方案, objectType=article, longId=26580, objectId=5fbf26580ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fbf26580ec, replyNumber=0, likeNumber=71, createdTime=2014-10-06, rootId=0, userName=12498768m24(暂无昵称), userId=6bb734392571, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fbf26580ec, moduleTitle=Gastroenterology：降低利巴韦林剂量为控制三联治疗1型HCV感染患者继发贫血的**方案, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5fbf26580ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738231, encodeId=c5741e382311a, content=<a href='/topic/show?id=cbea19e8944' target=_blank style='color:#2F92EE;'>#三联治疗#</a>, objectTitle=ADA:新诊断2型糖尿病患者宜初始接受三联治疗, objectType=article, longId=20581, objectId=9c34205812e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c34205812e, replyNumber=0, likeNumber=87, createdTime=2013-07-12, rootId=0, userName=12498768m24(暂无昵称), userId=6bb734392571, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c34205812e, moduleTitle=ADA:新诊断2型糖尿病患者宜初始接受三联治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9c34205812e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738230, encodeId=4cc41e3823077, content=<a href='/topic/show?id=cbea19e8944' target=_blank style='color:#2F92EE;'>#三联治疗#</a>, objectTitle=晚期胃癌对多西他赛、顺铂和S-1三联治疗耐受, objectType=article, longId=2944, objectId=1f3e294460, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f3e294460, replyNumber=0, likeNumber=72, createdTime=2012-07-10, rootId=0, userName=12498768m24(暂无昵称), userId=6bb734392571, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f3e294460, moduleTitle=晚期胃癌对多西他赛、顺铂和S-1三联治疗耐受, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1f3e294460)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

三联治疗

2020-05-29

12498768m24(暂无昵称) (审核中...)

前往app查看评论内容

#三联治疗#

Ann Intern Med：经皮冠状动脉介入治疗后房颤双联和三联治疗效果比较

2020-05-26

12498768m24(暂无昵称) (审核中...)

前往app查看评论内容

#三联治疗#

BMJ：COPD：三联治疗PK双药或单药治疗

2018-12-13

12498768m24(暂无昵称) (审核中...)

前往app查看评论内容

#三联治疗#

Int J Cardiol：接受口服抗凝剂治疗的冠状动脉支架植入患者双重治疗与三联治疗比较

2018-11-17

12498768m24(暂无昵称) (审核中...)

前往app查看评论内容

#三联治疗#

Ann Inter Med：RA治疗方案成本效益谁更好：二联治疗&三联治疗？

2017-09-30

12498768m24(暂无昵称) (审核中...)

前往app查看评论内容

#三联治疗#

ESC全新重磅：房颤患者支架置入术后使用达比加群酯双联治疗大出血发生率显著低于华法林三联治疗

2018-07-11

12498768m24(暂无昵称) (审核中...)

前往app查看评论内容

#三联治疗#

Am J Resp Crit Care:慢阻肺患者：三联治疗vs ICS/LABA

2018-05-27

12498768m24(暂无昵称) (审核中...)

前往app查看评论内容

#三联治疗#

Intern Med J：难治性幽门螺杆菌感染：基于左氧氟沙星的三联治疗可委以重任

2017-09-01

12498768m24(暂无昵称) (审核中...)

前往app查看评论内容

#三联治疗#

Ann Intern Med:活动性类风湿关节炎三联治疗vs生物治疗：成本效果分析

2017-08-21

12498768m24(暂无昵称) (审核中...)

前往app查看评论内容

#三联治疗#

Gastroenterology：降低利巴韦林剂量为控制三联治疗1型HCV感染患者继发贫血的**方案

2014-10-06

12498768m24(暂无昵称) (审核中...)

前往app查看评论内容

#三联治疗#

ADA:新诊断2型糖尿病患者宜初始接受三联治疗

2013-07-12

12498768m24(暂无昵称) (审核中...)

前往app查看评论内容

#三联治疗#

晚期胃癌对多西他赛、顺铂和S-1三联治疗耐受

2012-07-10

科室
- - 订阅+
  - 更多科室
工具
服务